These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38820101)

  • 1. Erythrodermic Pityriasis Rubra Pilaris Following COVID-19 Vaccination.
    Abdelkader HA; Khedr H; El-Komy MH
    Cutis; 2024 Apr; 113(4):E22-E24. PubMed ID: 38820101
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythrodermic pityriasis rubra pilaris after SARS-CoV-2 vaccination with concomitant COVID-19 infection.
    Gambichler T; Scheel CH; Arafat Y; Kautz O; Boms S
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):e675-e676. PubMed ID: 35536694
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on: 'Clinical characteristics of patients with pityriasis rubra pilaris following SARS-CoV-2 vaccination' by Gambichler.
    Potestio L; Martora F; Villani A; Megna M; Ruggiero A
    J Eur Acad Dermatol Venereol; 2023 Oct; 37(10):e1196-e1197. PubMed ID: 37326210
    [No Abstract]   [Full Text] [Related]  

  • 4. Pityriasis rubra pilaris following inactivated SARS-CoV-2 vaccine (CoronaVac).
    Zhang LW; Wang WJ; Fu LX; Lu YH; Chen T; Xu RH
    J Eur Acad Dermatol Venereol; 2023 Mar; 37(3):e287-e288. PubMed ID: 36504416
    [No Abstract]   [Full Text] [Related]  

  • 5. Pityriasis rubra pilaris in association with inactivated SARS-CoV-2 vaccine (CoronaVac).
    Fernández LT; Pérez-Garza DM; delaO-Escamilla A; Yamallel-Ortega LA; Cuellar-Barboza A; Ocampo-Candiani J; Chavez-Alvarez S
    Dermatol Ther; 2022 Jun; 35(6):e15455. PubMed ID: 35297142
    [No Abstract]   [Full Text] [Related]  

  • 6. Successful treatment of erythrodermic pityriasis rubra pilaris with acitretin.
    Atzori L; Zanniello R; Lappi A; Pinna AL; Ferreli C; Rongioletti F; Pilloni L
    Dermatol Ther; 2018 Sep; 31(5):e12694. PubMed ID: 30230135
    [No Abstract]   [Full Text] [Related]  

  • 7. Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine.
    Sechi A; Pierobon E; Pezzolo E; Germi L; Trevisan G; Zardo D; Riva G; Mondino S; Naldi L
    Clin Exp Dermatol; 2022 Feb; 47(2):437-440. PubMed ID: 34617317
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pityriasis rubra pilaris after COVID-19 vaccination: causal relationship or coincidence?].
    Bramhoff AC; Wesselmann U; Bender ST; Berghoff AV; Hofmann SC; Balakirski G
    Dermatologie (Heidelb); 2022 Aug; 73(8):634-637. PubMed ID: 35296923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eruptive seborrheic keratoses associated with erythrodermic pityriasis rubra pilaris. Possible role of retinoid therapy.
    Schwengle LE; Rampen FH
    Acta Derm Venereol; 1988; 68(5):443-5. PubMed ID: 2461032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pityriasis rubra pilaris after Vaxzevria® COVID-19 vaccine.
    Lladó I; Butrón B; Sampedro-Ruiz R; Fraga J; de Argila D
    J Eur Acad Dermatol Venereol; 2021 Dec; 35(12):e833-e835. PubMed ID: 34310778
    [No Abstract]   [Full Text] [Related]  

  • 11. Pityriasis rubra pilaris following booster dose of mRNA (Pfizer-BioNTech) COVID-19 vaccine.
    Hlaca N; Zagar T; Kastelan M; Peternel S; Brajac I; Dujmovic-Hasanbegovic K; Prpic-Massari L
    Dermatol Ther; 2022 Nov; 35(11):e15791. PubMed ID: 36029037
    [No Abstract]   [Full Text] [Related]  

  • 12. Erythroderma secondary to pityriasis rubra pilaris.
    Gomez-Moyano E; Crespo-Erchiga A
    Indian J Med Res; 2019 Aug; 150(2):206-207. PubMed ID: 31670278
    [No Abstract]   [Full Text] [Related]  

  • 13. Comment on 'Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine'.
    Potestio L; Genco L; Noto M; Fabbrocini G; Battista T; Martora F
    Clin Exp Dermatol; 2023 Jan; 48(1):44-45. PubMed ID: 36669180
    [No Abstract]   [Full Text] [Related]  

  • 14. Comment on: 'Pityriasis rubra pilaris-like eruption following mRNA COVID-19 vaccine'.
    Mungmunpuntipantip R; Wiwanitkit V
    Clin Exp Dermatol; 2022 Jun; 47(6):1195-1196. PubMed ID: 35187721
    [No Abstract]   [Full Text] [Related]  

  • 15. Pityriasis rubra pilaris: evolution of challenges in promising treatment options.
    Sehgal VN; Srivastava G; Verma P
    Skinmed; 2012; 10(1):18-23. PubMed ID: 22324172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to "An old entity, a new trigger: Post COVID-19 vaccine pityriasis rubra pilaris".
    Mungmunpuntipantip R; Wiwanitkit V
    Int J Risk Saf Med; 2022; 33(3):333. PubMed ID: 35466959
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pityriasis rubra pilaris in erythrodermic form. Discussion of a tumor of the cheek].
    Duperrat B; Puissant A; Pringuet R; Lauret P
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(3):293-4. PubMed ID: 4235571
    [No Abstract]   [Full Text] [Related]  

  • 18. Pityriasis rubra pilaris after COVID-19 vaccination: successful treatment with ustekinumab.
    Vieira Granja B; Amoedo P; Gomes NP; Costa C; Azevedo F; Magina S
    An Bras Dermatol; 2024; 99(4):642-644. PubMed ID: 38653608
    [No Abstract]   [Full Text] [Related]  

  • 19. Transient eruptive seborrhoeic keratoses associated with erythrodermic pityriasis rubra pilaris.
    Sahin MT; Oztürkcan S; Ermertcan AT; Saçar T; Türkdogan P
    Clin Exp Dermatol; 2004 Sep; 29(5):554-5. PubMed ID: 15347352
    [No Abstract]   [Full Text] [Related]  

  • 20. Papules and plaques from head to foot. Pityriasis rubra pilaris.
    Monroe JR
    JAAPA; 2012 Sep; 25(9):18. PubMed ID: 22991881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.